Please wait while the formulary information is being retrieved.
SITAVIG (acyclovir)
- Herpes labialis
50 mg buccal tablet
- Place 1 tablet (50 mg) to upper gum above incisor (same side; within 1 hr of symptoms); hold in place by buccal route once allow to dissolve
Herpes labialis
- Place 1 tablet (50 mg) to the upper gum just above incisor tooth on same side as symptoms, hold in place for 30 seconds on the outside of upper lip by buccal route once leave in place until tablet dissolves; use within 1Hr of symptoms
- Place 1 tablet (50 mg) to upper gum above incisor (same side; within 1 hr of symptoms); hold in place by buccal route once allow to dissolve
- measles,mumps,rub,varicel(PF)
- Proquad (pf)
- varicella virus vacc live (PF)
- Varivax (pf)
- Zostavax (pf)
- zoster vaccine live (PF)
Contraindicated
- tizanidine
- Zanaflex
Severe
Moderate
- Atripla
- Complera
- efavirenz-emtricitabin-tenofov
- elvitegr-cobicist-emtric-tenof
- emtricitab-rilpivirine-tenofov
- emtricitabine-tenofovir
- Stribild
- tenofovir disoproxil fumarate
- Truvada
- Viread
- None
Contraindicated
- None
Severe
Moderate
- No disease contraindications
SITAVIG (acyclovir)
- Herpes labialis
- None
- Headache disorder
- Treatment site sequelae
More Frequent
Severe
Less Severe
- None
- Aphthous stomatitis
- Dizziness
- Erythema
- Gingival pain
- Lethargy
Less Frequent
Severe
Less Severe
Rare / Very Rare
Severe
- Skin rash
Less Severe
- None
Contraindicated
None
Severe Precaution
None
Management or Monitoring Precaution
Acyclovir (Buccal)
Potential choking risk with younger children. No safety and efficacy established.
- 1 Day – 18 Years
- Potential choking risk with younger children. No safety and efficacy established.
Acyclovir
- Severity Level:
B
- Additional Notes:
Contraindicated
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
Precaution Exists
None
| General | Excretion Potential | Effect on Infant | Notes |
| None |
No Known Risk
Acyclovir (topical, Buccal)
Unlikely to be excreted since dose is small & systemic absorption is minimal
| General | Excretion Potential | Effect on Infant | Notes |
| No known risks; does not adversely affect lactation | Unknown | No adverse effect | Unlikely to be excreted since dose is small & systemic absorption is minimal |
Contraindicated
None
Precaution Exists
None
No Known Risk
None
- None
| Herpes labialis | |
| B00.1 | Herpesviral vesicular dermatitis |
| 0-9 | A-Z |
|---|---|
| B00.1 | Herpesviral vesicular dermatitis |
Formulary Reference Tool